Mml Investors Services, LLC Abiomed Inc Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $40,738 - $50,645	168 Added 1.69%	10,106 $2.48 Million
Q2 2022 Aug 12, 2022	SELL	$224.73 - $338.64 $40,451 - $60,955	-180 Reduced 1.78%	9,938 $2.46 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $2.34 Million - $3.09 Million	8,429 Added 499.05%	10,118 $3.35 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $76,360 - $94,322	254 Added 17.7%	1,689 $607,000
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $116,941 - $141,827	377 Added 35.63%	1,435 $467,000
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $20,754 - $27,742	79 Added 8.07%	1,058 $330,000
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $32,023 - $39,774	112 Added 12.92%	979 $312,000
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $157,676 - $202,949	-626 Reduced 41.93%	867 $281,000
Q3 2020 Nov 13, 2020	BUY	$255.22 - $317.0 $381,043 - $473,281	1,493 New	1,493 $414,000
Q4 2019 Feb 11, 2020	SELL	$159.31 - $223.54 $197,385 - $276,966	-1,239 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $75,632 - $120,068	430 Added 53.15%	1,239 $220,000
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $93,106 - $105,712	-371 Reduced 31.44%	809 $211,000
Q1 2019 May 10, 2019	BUY	$276.39 - $362.25 $3,593 - $4,709	13 Added 1.11%	1,180 $337,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $1,405 - $2,221	5 Added 0.43%	1,167 $379,000
Q3 2018 Nov 07, 2018	SELL	$354.53 - $449.75 $25,880 - $32,831	-73 Reduced 5.91%	1,162 $523,000
Q2 2018 Aug 13, 2018	BUY	$278.07 - $446.21 $85,923 - $137,878	309 Added 33.37%	1,235 $505,000
Q1 2018 May 11, 2018	BUY	$192.49 - $295.85 $178,245 - $273,957	926 New	926 $269,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account